Antipsychotic-induced weight gain is a major management problem for clinicians. It has
been shown that weight gain and obesity lead to increased cardiovascular and …

These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …

Second generation antipsychotics (SGAs), such as clozapine, olanzapine, risperidone and
quetiapine, are among the most effective therapies to stabilize symptoms schizophrenia (SZ) …

One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

Carefully designed to balance coverage of theoretical and practical principles,
Fundamentals of Water Treatment Unit Processes delineates the principles that support …

The use of second‐generation antipsychotics (SGAs) is associated with metabolic side
effects including weight gain, diabetes mellitus and an atherogenic lipid profile. These …

Antipsychotic-related weight gain and metabolic effects are a critical outcome for patients
requiring these medications. A literature search using MEDLINE, Web of Science, PsycNET …

Background: Antipsychotic-induced metabolic adversities are often difficult to manage.
Using concomitant medications to counteract these adversities may be a rational option …

Objective: Second-generation, or atypical, antipsychotics effectively treat psychiatric illness
in children and adolescents. However, weight gain and abnormalities in insulin sensitivity …

Metabolic syndrome with the atypical antipsychotics : Current Opinion in Endocrinology,
Diabetes and Obesity Metabolic syndrome with the atypical antipsychotics : Current Opinion in …